Psychiatrisches Zentrum Nordbaden
- Address
- Heidelberger Straße 1A, 69168 Wiesloch, Germany
Psychiatrisches Zentrum Nordbaden - Addiction Psychiatry Research
The Psychiatrisches Zentrum Nordbaden is a specialized psychiatric research center dedicated to advancing treatment strategies for substance use disorders and mental health conditions. The center focuses on innovative pharmacological approaches to addiction treatment, with particular emphasis on developing evidence-based interventions for patients struggling with alcohol and substance dependencies.
- Alcohol dependence treatment and craving reduction
- Novel cannabinoid-based therapeutic interventions
- Combination pharmacotherapy for addiction disorders
The center is actively investigating the therapeutic potential of Cannabidiol (CBD) combined with Naltrexone for managing alcohol craving in patients with alcohol dependence. This research represents a cutting-edge approach to addiction treatment, exploring how combination therapies can enhance standard care protocols and improve outcomes for individuals battling alcohol use disorder through targeted reduction of craving symptoms.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Psychiatrisches Zentrum Nordbaden
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Cannabidiol and Naltrexone on Cue-Induced Alcohol Craving in Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial | Zentralinstitut Fuer Seelische Gesundheit | Phase II | Recruiting | Jun 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cannabidiol | 1 | Unknown | 2025-06-16 | 2025-06-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.